A medically trained LLM screened 1476 EMR records in one week, synthesizing structured variables and free-text notes to ...
The rise in CRC in adults younger than 65 underscores the need for early screening and prevention efforts. The report’s ...
In 524,817 adults with T2D, GLP-1 RA use was associated with lower incident alcohol, cocaine, cannabis, opioid, and nicotine ...
Medicaid managed care organizations should prioritize children in low-opportunity neighborhoods to optimize health care ...
Todd Schlesinger, MD, is the founder and director of the Dermatology & Laser Center of Charleston and the Clinical Research ...
Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space ...
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to ...
In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and Diagnostic Challenges,’ ...
Health inequities add $360 billion yearly; see how employers uncover disparities in claims, rethink deductibles, and invest ...
In this episode titled, ‘Economic Impact and Unmet Needs in ATTR-CM,’ Dr. Alexander outlines the key cost drivers of ATTR-CM from a clinical perspective, noting that patients typically see 4 to 5 ...
As the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up, leading HIV experts reflected on the ...
The management of smoldering multiple myeloma (MM) is undergoing a significant transformation, driven by growing evidence that early intervention can meaningfully delay progression to active disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results